Literature DB >> 8832029

Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT.

N Schaap1, R Raymakers, A Schattenberg, J P Ottevanger, T de Witte.   

Abstract

A 37-year-old male developed massive pleural effusion leading to respiratory failure and electromechanical dissociation within 24 h after the second dose of 4200 mg cyclophosphamide (CY) during conditioning for allogeneic bone marrow transplantation for chronic myelogenous leukemia. After resuscitation and bilateral pleural drainage he recovered within 1 day. Subsequently, total body irradiation was given and with a delay of 1 day the transplantation procedure was continued without major complications. No explanation for this idiosyncratic reaction other than the administration of high dose CY in combination with mesna rescue was found. This reaction has not been reported before in the literature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832029

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.

Authors:  Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Joseph P Uberti
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

2.  Radiologic evaluation of pulmonary injury following carmustine- and cyclophosphamide-based preparative regimen for autologous peripheral blood stem cell transplantation in children.

Authors:  Yu Jin Kim; Woo Sun Kim; Young Hun Choi; Jung-Eun Cheon; Jung Yoon Choi; Hyoung Jin Kang; Ji-Eun Park; Young Jin Ryu; In-One Kim
Journal:  Pediatr Radiol       Date:  2018-08-18

Review 3.  Non-infectious pulmonary complications after bone marrow transplantation.

Authors:  I Khurshid; L C Anderson
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

4.  The yield and safety of thoracentesis in hematopoietic stem cell transplantation recipients.

Authors:  Abdulgadir K Adam; Mahmud Zamlut; Ayman O Soubani
Journal:  Lung       Date:  2007-08-25       Impact factor: 3.777

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.